Eterna Therapeutics Depreciation And Amortization Over Time

ERNA Stock  USD 0.29  0.03  9.38%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Eterna Therapeutics Performance and Eterna Therapeutics Correlation.
For information on how to trade Eterna Stock refer to our How to Trade Eterna Stock guide.
  
As of December 14, 2024, Depreciation And Amortization is expected to decline to about 1.1 M.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eterna Therapeutics. If investors know Eterna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eterna Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.31)
Revenue Per Share
0.03
Return On Assets
(0.29)
Return On Equity
(11.54)
The market value of Eterna Therapeutics is measured differently than its book value, which is the value of Eterna that is recorded on the company's balance sheet. Investors also form their own opinion of Eterna Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Eterna Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eterna Therapeutics' market value can be influenced by many factors that don't directly affect Eterna Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eterna Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eterna Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eterna Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Depreciation And Amortization Analysis

Compare Eterna Therapeutics and related stocks such as Arcus Biosciences, Cullinan Oncology LLC, and Annexon Depreciation And Amortization Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
RCUS1.3 M1.3 M1.3 M1.3 M1.3 M1.3 M1.3 M2.6 M3.7 M3.6 M4.4 M7.1 M14 MM6.1 M
CGEM43 K43 K43 K43 K43 K43 K43 K43 K43 K70 K62 K53 K93 K310 K325.5 K
ANNX488 K488 K488 K488 K488 K488 K488 K488 K488 K493 K667 K2.1 M2.1 M2.1 M1.5 M
GPCR20 K20 K20 K20 K20 K20 K20 K20 K20 K20 K20 K266.4 K277 K316 K241.8 K
RLAY2.2 M2.2 M2.2 M2.2 M2.2 M2.2 M2.2 M2.2 M2.2 M2.8 M3.5 M3.9 M4.1 M5.3 MM
REVB3.8 K3.8 K3.8 K3.8 K3.8 K3.8 K3.8 K3.8 K3.8 K3.8 K3.8 K69.2 K40 K25 K38 K
ZURA236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K236.6 K228.5 K167.9 K168.8 K
PHIO163 K163 K147 K99 K87 K77 K53 K70 K81 K67 K183 K75 K193 K184 K125.1 K
ZVSA10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K10.4 K9.4 K8.3 K
RNAZ34.034.034.034.034.034.034.034.034.034.0726.6 K42.5 K98.6 K516.7 K304.6 K
DAWN(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)155 K199 K531 K383 K278.5 K
ABOS147 K147 K147 K147 K147 K147 K147 K147 K147 K147 K7.9 MK169 K184 K174.8 K
XFOR389 K389 K389 K389 K389 K389 K285 K195 K155 K7.8 M351 K1.9 MM419 K398.1 K
INZY26 K26 K26 K26 K26 K26 K26 K26 K26 K83 K217 K1.1 M744 K833 K541.8 K
PALI51.9 K187.1 K211.1 K244.7 K348.6 K345.5 K337.5 K289.2 K185.8 K143.9 K146 K168 K167 KK3.8 K
UNCY(63 K)(63 K)(63 K)(63 K)(63 K)(63 K)(63 K)(63 K)(63 K)(63 K)M13 K161 K284 K386.4 K
IMMX1.3 K1.3 K1.3 K1.3 K1.3 K1.3 K1.3 K1.3 K1.3 K1.3 K2.3 K2.5 K2.1 K5.5 KK
APLS6.3 K6.3 K6.3 K6.3 K6.6 K53 M11.9 K11.9 K2.9 M5.2 M859 K1.5 M1.5 M1.7 M1.6 M
ITOS505 K505 K505 K505 K505 K505 K505 K505 K505 K6.3 M535 K615 K813 K898 K1.3 M
TCRX519 K519 K519 K519 K519 K519 K519 K519 K519 K519 K1.2 M3.3 M5.1 M5.4 M3.4 M

Eterna Therapeutics and related stocks such as Arcus Biosciences, Cullinan Oncology LLC, and Annexon Depreciation And Amortization description

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

My Equities

My Current Equities and Potential Positions

Eterna Therapeutics
ERNA
ClassificationComputers
LocationNew York; U.S.A
ExchangeNASDAQ Exchange
USD 0.29
When determining whether Eterna Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eterna Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eterna Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eterna Therapeutics Stock:
Check out Eterna Therapeutics Performance and Eterna Therapeutics Correlation.
For information on how to trade Eterna Stock refer to our How to Trade Eterna Stock guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Eterna Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Eterna Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Eterna Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...